Garden State Investment Advisory Services LLC Makes New $1.64 Million Investment in MeiraGTx Holdings plc (NASDAQ:MGTX)

Garden State Investment Advisory Services LLC purchased a new position in shares of MeiraGTx Holdings plc (NASDAQ:MGTX) in the third quarter, Holdings Channel.com reports. The fund purchased 392,400 shares of the company’s stock, valued at approximately $1,636,000.

Several other institutional investors and hedge funds have also modified their holdings of MGTX. BNP Paribas Financial Markets lifted its stake in shares of MeiraGTx by 142.5% in the 3rd quarter. BNP Paribas Financial Markets now owns 9,319 shares of the company’s stock valued at $39,000 after acquiring an additional 5,476 shares during the last quarter. China Universal Asset Management Co. Ltd. boosted its stake in shares of MeiraGTx by 97.0% during the third quarter. China Universal Asset Management Co. Ltd. now owns 14,886 shares of the company’s stock valued at $62,000 after purchasing an additional 7,330 shares in the last quarter. The Manufacturers Life Insurance Company raised its holdings in MeiraGTx by 19.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 17,763 shares of the company’s stock valued at $75,000 after buying an additional 2,839 shares during the last quarter. SG Americas Securities LLC acquired a new stake in MeiraGTx during the 3rd quarter worth approximately $82,000. Finally, Panagora Asset Management Inc. bought a new stake in MeiraGTx during the 2nd quarter worth approximately $97,000. 67.48% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of brokerages have recently commented on MGTX. Chardan Capital reiterated a “buy” rating and set a $36.00 price target on shares of MeiraGTx in a report on Monday, November 18th. Royal Bank of Canada increased their price target on MeiraGTx from $9.00 to $11.00 and gave the company an “outperform” rating in a research note on Thursday, November 14th.

MeiraGTx Trading Up 1.7 %

Shares of MeiraGTx stock traded up $0.10 on Friday, hitting $6.11. 36,855 shares of the company’s stock traded hands, compared to its average volume of 203,013. The company has a debt-to-equity ratio of 0.86, a current ratio of 2.34 and a quick ratio of 2.34. The company has a fifty day moving average of $5.92 and a two-hundred day moving average of $4.93. The company has a market capitalization of $477.51 million, a price-to-earnings ratio of -4.97 and a beta of 1.25. MeiraGTx Holdings plc has a one year low of $3.85 and a one year high of $7.60.

MeiraGTx Company Profile

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia.